How Google Could Transform Medtech—and Cheat Death

September 29, 2014

9 Slides

How Google Could Transform Medtech—and Cheat Death

Updated December 9, 2015

Google’s cofounders may have once downplayed that they’re interested in turning the tech giant into a healthcare company. But their company sure hasn’t been acting that way these days.

While Apple has had some hiccups when it comes to its goals of becoming a go-to place for health tracking and data, Google has made waves with far more focused medical device innovations—not to mention an effort to reverse the effects of aging.

Even Google Glass, better known as an accessory for creepy tech types before its initial version was retired, still turned out to be a pretty useful tool for surgeons—with Stanford University researchers extolling Glass’ benefits.

Now Google’s foray into the life sciences has grown into a sister spin-off company called Verify, with details continuing to come out about new technologies in the works. The new structure, in which "moonshot" ventures such as Verify are separated from Google under the new Alphabet parent company, could give Google founders Larry Page and Sergey Brin more room to experiment, with investors less worried because Google is more sheltered from the risks. 

Verily’s mission is to “bring together technology and life sciences to uncover new truths about health and disease, according to the company's website.

Read on to find out about the work Google (now consolidating its life science activities under Verify) has been doing.

Continue>>

Learn more about cutting-edge medical devices at MD&M West, February 9–11 at the Anaheim Convention Center in Anaheim, CA.

Chris Newmarker is senior editor of MPMN and Qmed. Follow him on Twitter at @newmarkerBrian Buntz is the editor-in-chief of MPMN and Qmed. Follow him on Twitter at @brian_buntz.

Like what you're reading? Subscribe to our daily e-newsletter.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like